BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15269711)

  • 1. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
    Nomura S; Merched A; Nour E; Dieker C; Oka K; Chan L
    Gene Ther; 2004 Oct; 11(20):1540-8. PubMed ID: 15269711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS; Martins I; Davidson BL
    J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
    Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
    Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice.
    Li D; Liu Y; Chen J; Velchala N; Amani F; Nemarkommula A; Chen K; Rayaz H; Zhang D; Liu H; Sinha AK; Romeo F; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2006 Jun; 344(3):701-7. PubMed ID: 16631603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
    Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
    J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor.
    Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L
    J Biol Chem; 1996 Mar; 271(12):6852-60. PubMed ID: 8636110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
    Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.
    Leppänen P; Koota S; Kholová I; Koponen J; Fieber C; Eriksson U; Alitalo K; Ylä-Herttuala S
    Circulation; 2005 Aug; 112(9):1347-52. PubMed ID: 16129816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved.
    Dai J; Miller BA; Lin RC
    Alcohol Clin Exp Res; 1997 Feb; 21(1):11-8. PubMed ID: 9046367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
    Shichiri M; Tanaka A; Hirata Y
    Gene Ther; 2003 May; 10(9):827-31. PubMed ID: 12704424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
    Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
    Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
    J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
    Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
    Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse.
    Tomita N; Morishita R; Koike H; Hashizume M; Notake M; Fujitani B; Kaneda Y; Horiuchi M; Ogihara T
    Int J Mol Med; 2002 Aug; 10(2):137-43. PubMed ID: 12119548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene.
    Kozarsky KF; Jooss K; Donahee M; Strauss JF; Wilson JM
    Nat Genet; 1996 May; 13(1):54-62. PubMed ID: 8673104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for gene therapy of familial hypercholesterolemia.
    Wilson JM; Chowdhury JR
    Mol Biol Med; 1990 Jun; 7(3):223-32. PubMed ID: 2215209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.